Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance.

CXCR4 IgM-MGUS MYD88 WM cfDNA liquid biopsy lncRNA miRNA

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
12 Apr 2022
Historique:
received: 03 03 2022
revised: 07 04 2022
accepted: 09 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Waldenström Macroglobulinemia (WM) is an indolent lymphoplasmacytic lymphoma, characterized by the production of excess immunoglobulin M monoclonal protein. WM belongs to the spectrum of IgM gammopathies, ranging from asymptomatic IgM monoclonal gammopathy of undetermined significance (IgM-MGUS), through IgM-related disorders and asymptomatic WM to symptomatic WM. In recent years, its complex genomic and transcriptomic landscape has been extensively explored, hereby elucidating the biological mechanisms underlying disease onset, progression and therapy response. An increasing number of mutations, cytogenetic abnormalities, and molecular signatures have been described that have diagnostic, phenotype defining or prognostic implications. Moreover, cell-free nucleic acid biomarkers are increasingly being investigated, benefiting the patient in a minimally invasive way. This review aims to provide an extensive overview of molecular biomarkers in WM and IgM-MGUS, considering current shortcomings, as well as potential future applications in a precision medicine approach.

Identifiants

pubmed: 35454017
pii: diagnostics12040969
doi: 10.3390/diagnostics12040969
pmc: PMC9028641
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : International Waldenstrom's Macroglobulinemia Foundation
Organisme : Fondi di Ricerca Locale, Università degli Studi di Torino, Italy

Références

J Clin Oncol. 2020 Apr 10;38(11):1198-1208
pubmed: 32083995
Leukemia. 2013 Aug;27(8):1722-8
pubmed: 23446312
Cancers (Basel). 2021 Apr 12;13(8):
pubmed: 33921415
Best Pract Res Clin Haematol. 2016 Jun;29(2):148-155
pubmed: 27825460
Biomed Res Int. 2018 Oct 04;2018:6728128
pubmed: 30402490
Mol Oncol. 2012 Dec;6(6):590-610
pubmed: 23102669
Blood. 2013 Mar 14;121(11):2051-8
pubmed: 23321251
Blood. 2014 Mar 13;123(11):1637-46
pubmed: 24366360
Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):208-10
pubmed: 23477935
Clin Lymphoma. 2005 Mar;5(4):265-9
pubmed: 15794862
Br J Cancer. 2006 Jan 30;94(2):179-83
pubmed: 16404435
J Exp Med. 2001 Dec 3;194(11):1625-38
pubmed: 11733577
Cancer Genet Cytogenet. 2006 Sep;169(2):150-3
pubmed: 16938573
Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3627-32
pubmed: 15738415
Ann Hematol. 2018 Mar;97(3):475-484
pubmed: 29353304
PLoS One. 2013 Nov 05;8(11):e80088
pubmed: 24224040
Br J Haematol. 2020 Feb;188(4):511-515
pubmed: 31588566
Int J Mol Sci. 2020 Aug 08;21(16):
pubmed: 32784523
Clin Lymphoma Myeloma. 2009 Mar;9(1):36-8
pubmed: 19362968
Haematologica. 2012 Sep;97(9):1281-90
pubmed: 22773606
Blood Adv. 2018 Nov 13;2(21):2937-2946
pubmed: 30401751
Blood Adv. 2022 Jan 11;6(1):189-199
pubmed: 34788399
PLoS One. 2019 Sep 4;14(9):e0221941
pubmed: 31483817
Blood Adv. 2021 Jun 8;5(11):2505-2514
pubmed: 34047776
Cancer Discov. 2021 Apr;11(4):858-873
pubmed: 33811121
Am J Hematol. 2020 Jun;95(6):E148-E150
pubmed: 32242972
Cell. 2019 Apr 4;177(2):384-398.e11
pubmed: 30853218
N Engl J Med. 2015 Apr 9;372(15):1430-40
pubmed: 25853747
Semin Oncol. 2003 Apr;30(2):110-5
pubmed: 12720118
Adv Exp Med Biol. 2020;1253:3-55
pubmed: 32445090
Hemasphere. 2021 Jul 19;5(8):e624
pubmed: 34291197
Leukemia. 2018 Dec;32(12):2617-2625
pubmed: 30026568
PLoS Genet. 2013 Apr;9(4):e1003373
pubmed: 23593011
Biomed Res Int. 2014;2014:809103
pubmed: 25197661
Br J Haematol. 2019 Nov;187(3):356-363
pubmed: 31267520
Ann Hematol. 2017 Jun;96(6):971-976
pubmed: 28280994
Am J Clin Pathol. 2013 Sep;140(3):387-94
pubmed: 23955458
Leuk Res. 2016 Dec;51:41-48
pubmed: 27890075
Leukemia. 2014 Feb;28(2):447-9
pubmed: 24135828
Blood. 2016 Aug 11;128(6):827-38
pubmed: 27301862
Br J Haematol. 2019 Jan;184(2):242-245
pubmed: 30183082
Am J Hematol. 2021 Jul 1;96(7):E250-E253
pubmed: 33819355
Blood. 2010 Sep 2;116(9):1506-14
pubmed: 20519629
Cancer Discov. 2020 Nov;10(11):1635-1644
pubmed: 33037026
Leukemia. 2015 Jan;29(1):169-76
pubmed: 24912431
BMC Biol. 2018 Dec 24;16(1):149
pubmed: 30583727
Blood. 2009 Apr 30;113(18):4391-402
pubmed: 19074725
Nat Rev Genet. 2009 Mar;10(3):155-9
pubmed: 19188922
Br J Haematol. 2021 Aug;194(4):730-733
pubmed: 33713429
J Cutan Pathol. 2017 Jul;44(7):625-631
pubmed: 28370087
Cell Death Dis. 2021 May 11;12(5):468
pubmed: 33976116
Blood. 2013 May 30;121(22):4504-11
pubmed: 23532735
Blood. 2014 May 1;123(18):2791-6
pubmed: 24553177
Sci Adv. 2022 Jan 21;8(3):eabl4644
pubmed: 35044826
Eur J Cancer. 2006 Jul;42(11):1564-73
pubmed: 16765041
Expert Rev Hematol. 2019 Oct;12(10):873-881
pubmed: 31343930
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
PLoS One. 2018 Oct 4;13(10):e0204589
pubmed: 30286096
Tumour Biol. 2015 Dec;36(12):9739-52
pubmed: 26156801
Oncotarget. 2019 May 21;10(36):3400-3407
pubmed: 31164961
Aging (Albany NY). 2019 Jun 1;11(11):3561-3573
pubmed: 31152142
Br J Haematol. 2007 Jan;136(1):80-6
pubmed: 17222197
Oncotarget. 2016 Dec 13;7(50):82400-82410
pubmed: 27689399
N Engl J Med. 2008 Mar 13;358(11):1148-59
pubmed: 18337604
Am J Hum Genet. 2006 Oct;79(4):695-701
pubmed: 16960805
Am J Hematol. 2015 Mar;90(3):E51-2
pubmed: 25428891
Blood. 2014 Jun 26;123(26):4120-31
pubmed: 24711662
Blood. 2016 Jun 23;127(25):3237-52
pubmed: 27143257
Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):152-6
pubmed: 21454220
Am J Hematol. 2018 Feb;93(2):187-194
pubmed: 29080258
J Thorac Oncol. 2018 Sep;13(9):1248-1268
pubmed: 29885479
Semin Oncol. 2003 Apr;30(2):182-6
pubmed: 12720133
Exp Mol Pathol. 2014 Aug;97(1):57-65
pubmed: 24842316
Clin Chim Acta. 2014 Apr 20;431:255-9
pubmed: 24583225
N Engl J Med. 2018 Jan 18;378(3):241-249
pubmed: 29342381
J Blood Med. 2021 Aug 30;12:795-807
pubmed: 34512060
J Cell Biol. 2021 Jul 5;220(7):
pubmed: 33956941
Front Immunol. 2020 Dec 01;11:602868
pubmed: 33343574
Nat Rev Genet. 2011 Nov 18;12(12):861-74
pubmed: 22094949
Br J Haematol. 2018 Feb;180(3):374-380
pubmed: 29181840
Clin Cancer Res. 2016 Mar 15;22(6):1480-8
pubmed: 26490317
Br J Haematol. 2021 Mar;192(5):843-852
pubmed: 32780894
Clin Cancer Res. 2017 Oct 15;23(20):6325-6335
pubmed: 28754818
Clin Chim Acta. 2018 May;480:199-205
pubmed: 29470951
Haematologica. 2018 Sep;103(9):e408-e411
pubmed: 29599202
JAMA Oncol. 2017 Sep 01;3(9):1257-1265
pubmed: 28056114
Leukemia. 2017 Jun;31(6):1355-1362
pubmed: 27840426
Pathology. 2020 Feb;52(2):167-178
pubmed: 31902622
Leukemia. 2021 Feb;35(2):333-345
pubmed: 33273682
Diagnostics (Basel). 2021 Apr 26;11(5):
pubmed: 33926007
Cell Res. 2014 Jun;24(6):766-9
pubmed: 24710597
Biochem Biophys Res Commun. 2018 Sep 3;503(1):385-390
pubmed: 29902450
Br J Haematol. 2016 Mar;172(5):735-44
pubmed: 26659815
N Engl J Med. 2012 Dec 6;367(23):2255-6; author reply 2256-7
pubmed: 23215570
Am J Hematol. 2021 Dec 1;96(12):1569-1579
pubmed: 34462944
Cell Death Dis. 2019 Feb 6;10(2):106
pubmed: 30728351
Blood. 2006 Oct 15;108(8):2755-63
pubmed: 16804116
Blood. 2013 Sep 26;122(13):2284-5
pubmed: 24072850
Blood. 2004 Oct 1;104(7):2134-42
pubmed: 14764523
J Exp Clin Cancer Res. 2019 Feb 6;38(1):54
pubmed: 30728056
Cancer Cell. 2014 Nov 10;26(5):707-21
pubmed: 25446899
Blood. 2012 Aug 23;120(8):1678-86
pubmed: 22797699
Neoplasia. 2021 Apr;23(4):361-374
pubmed: 33735664
Ann Hematol. 2020 Aug;99(8):1763-1769
pubmed: 32577844
Oncogene. 2017 Oct 12;36(41):5661-5667
pubmed: 28604750
Epigenomics. 2021 Jan;13(2):129-144
pubmed: 33356554
J Clin Oncol. 2005 Jul 20;23(21):4662-8
pubmed: 16034042
Lab Invest. 2018 Dec;98(12):1657-1669
pubmed: 30087459
Int J Mol Sci. 2018 Sep 21;19(10):
pubmed: 30248975
Leukemia. 2007 Mar;21(3):541-9
pubmed: 17252022
Haematologica. 2013 Apr;98(4):649-54
pubmed: 23065509
Br J Haematol. 2017 Dec;179(5):849-851
pubmed: 27605200
Br J Haematol. 2014 Nov;167(4):506-13
pubmed: 25160558
Blood. 2008 May 15;111(10):5068-77
pubmed: 18334673
Blood. 2009 Jun 25;113(26):6669-80
pubmed: 19401561
Anal Chim Acta. 2020 Jun 8;1115:61-85
pubmed: 32370870
Blood Cancer J. 2014 Feb 14;4:e183
pubmed: 24531446
N Engl J Med. 2012 Aug 30;367(9):826-33
pubmed: 22931316
Oncotarget. 2015 May 30;6(15):12837-61
pubmed: 25968566
Blood Adv. 2020 Dec 8;4(23):6009-6018
pubmed: 33284944
J Exp Med. 2014 Mar 10;211(3):413-26
pubmed: 24534189
Leukemia. 2014 Aug;28(8):1698-704
pubmed: 24509637
Blood. 2013 Feb 21;121(8):1296-303
pubmed: 23287861
J Pathol. 2005 Oct;207(2):243-9
pubmed: 16041695
Curr Oncol. 2010 Feb;17(1):70-80
pubmed: 20179807
Blood. 2013 Mar 28;121(13):2522-8
pubmed: 23355535
Cancer Res. 2017 Aug 1;77(15):3965-3981
pubmed: 28701486
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Br J Haematol. 2017 Oct;179(1):98-105
pubmed: 28786474
Br J Haematol. 2022 Apr;197(2):171-187
pubmed: 35020191
Blood. 2020 Oct 29;136(18):2038-2050
pubmed: 32731259
Blood. 2012 Feb 2;119(5):1162-72
pubmed: 22096249
Blood. 2017 Apr 6;129(14):1947-1957
pubmed: 28096087
Mayo Clin Proc. 2010 Sep;85(9):824-33
pubmed: 20702770
Br J Haematol. 2013 Jun;161(6):902-4
pubmed: 23560587
Leukemia. 2015 Oct;29(10):2015-23
pubmed: 25971364
Haematologica. 2018 Jun;103(6):1029-1037
pubmed: 29567768
Cancer Discov. 2019 Jun;9(6):796-811
pubmed: 31018969
Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):395-403.e1
pubmed: 27268124
Blood Cancer J. 2017 Aug 25;7(8):e591
pubmed: 28841204
Hum Genet. 2012 Oct;131(10):1627-38
pubmed: 22752797
Stem Cells. 2015 Jun;33(6):1985-97
pubmed: 25753650
Oncotarget. 2016 Mar 22;7(12):14814-30
pubmed: 26895470
Biomed Pharmacother. 2017 Aug;92:864-869
pubmed: 28599250
Blood. 2011 Nov 17;118(20):5540-9
pubmed: 21921047
EMBO Mol Med. 2009 Aug;1(5):288-95
pubmed: 19890474
Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):106-8
pubmed: 21454205
Clin Cancer Res. 2012 Dec 15;18(24):6609-22
pubmed: 23048077
Mod Pathol. 2009 Jun;22(6):807-16
pubmed: 19287458
Blood Adv. 2020 Sep 22;4(18):4550-4553
pubmed: 32956451
J Clin Oncol. 2021 Feb 20;39(6):565-575
pubmed: 32931398
Blood. 2011 May 12;117(19):5019-32
pubmed: 21300984
Leukemia. 2013 Jan;27(1):183-9
pubmed: 22944768
Cancer Res. 2009 Apr 15;69(8):3579-88
pubmed: 19351844
Blood Cancer J. 2016 Sep 09;6(9):e468
pubmed: 27611921
Lancet Oncol. 2015 May;16(5):541-9
pubmed: 25842160
Eur J Haematol. 2001 Jan;66(1):1-6
pubmed: 11168500
Nat Rev Immunol. 2014 Dec;14(12):821-6
pubmed: 25359439
BMC Cancer. 2019 Oct 10;19(1):937
pubmed: 31601173
Leukemia. 2020 Mar;34(3):919-923
pubmed: 31611623
Leukemia. 2006 Sep;20(9):1634-6
pubmed: 16838026
Lancet Haematol. 2020 Feb;7(2):e112-e121
pubmed: 31866281
Nat Rev Clin Oncol. 2017 Sep;14(9):531-548
pubmed: 28252003
Leuk Lymphoma. 2013 Mar;54(3):464-71
pubmed: 22860921
Leuk Lymphoma. 2015 Feb;56(2):420-5
pubmed: 24828863
Semin Cancer Biol. 2019 Oct;58:100-108
pubmed: 30684535
J Adv Pract Oncol. 2020 May-Jun;11(4):381-389
pubmed: 33604098
Immunol Lett. 2016 Sep;177:6-15
pubmed: 27363619
Blood. 2018 Apr 12;131(15):1720-1729
pubmed: 29358175
Nat Rev Genet. 2019 Nov;20(11):675-691
pubmed: 31395983
Blood Adv. 2019 Nov 12;3(21):3360-3374
pubmed: 31698464
Leukemia. 2019 Nov;33(11):2654-2661
pubmed: 31118465
Blood. 2015 Apr 9;125(15):2370-80
pubmed: 25655603
Oncogene. 2016 Jan 28;35(4):479-90
pubmed: 25893290
J Immunol. 2015 Sep 15;195(6):2908-16
pubmed: 26238488
Oncotarget. 2016 Aug 23;7(34):54174-54182
pubmed: 27527866
Indian J Hematol Blood Transfus. 2019 Jan;35(1):57-65
pubmed: 30828149
Clin Chem. 2021 Nov 1;67(11):1437-1439
pubmed: 34549290
Br J Haematol. 2017 Mar;176(5):822-824
pubmed: 26936399
Am J Hematol. 2021 Feb 1;96(2):258-269
pubmed: 33368476
Annu Rev Immunol. 2015;33:257-90
pubmed: 25581309
Blood Cancer J. 2016 Jan 15;6:e380
pubmed: 26771806
Blood Cancer J. 2011 Jun;1(6):e24
pubmed: 22829168
Nat Commun. 2017 Mar 17;8:14756
pubmed: 28303898
Haematologica. 2017 Dec;102(12):2077-2085
pubmed: 28983055
Blood. 2009 Apr 30;113(18):4163-70
pubmed: 19196866
Br J Haematol. 2015 Jun;169(6):795-803
pubmed: 25819228
Blood Res. 2016 Sep;51(3):181-186
pubmed: 27722129
Exp Hematol Oncol. 2021 Feb 16;10(1):13
pubmed: 33593440
Blood. 2012 May 10;119(19):4462-6
pubmed: 22451426
Cell Oncol (Dordr). 2017 Feb;40(1):97-103
pubmed: 27761889
J Leukoc Biol. 2019 Feb;105(2):339-351
pubmed: 30256449
N Engl J Med. 2021 May 20;384(20):1931-1941
pubmed: 34010532
Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):77-9
pubmed: 21454196

Auteurs

Daniela Drandi (D)

Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, 10126 Torino, Italy.

Philippe Decruyenaere (P)

Department of Hematology, Ghent University Hospital, 9000 Ghent, Belgium.
OncoRNALab, Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.

Martina Ferrante (M)

Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, 10126 Torino, Italy.

Fritz Offner (F)

Department of Hematology, Ghent University Hospital, 9000 Ghent, Belgium.

Jo Vandesompele (J)

OncoRNALab, Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.

Simone Ferrero (S)

Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, 10126 Torino, Italy.

Classifications MeSH